These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26327189)

  • 1. DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application.
    Antunes MV; Raymundo S; Wagner SC; Mattevi VS; Vieira N; Leite R; Reginato F; Capra MZ; Fogliatto L; Linden R
    Bioanalysis; 2015; 7(16):2105-17. PubMed ID: 26327189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First report of imatinib measurement in hair: Method development and preliminary evaluation of the relation between hair and plasma concentrations with therapeutic response in chronic myeloid leukemia.
    Capron A; Antunes MV; Wagner SC; Mattevi VS; Vieira N; Leite R; Reginato F; Capra M; Fogliatto L; Wallemacq P; Linden R
    Clin Chim Acta; 2016 Jan; 453():42-7. PubMed ID: 26657979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an hollow fiber solid phase microextraction method for the analysis of unbound fraction of imatinib and N-desmethyl imatinib in human plasma.
    Dong WC; Song MY; Zheng TL; Zhang ZQ; Jiang Y; Guo JL; Zhang YZ
    J Pharm Biomed Anal; 2024 Nov; 250():116405. PubMed ID: 39151298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of total and unbound imatinib and metabolite LC-MS/MS assay to understand individual responses in CML and GIST patients.
    Streit F; Binder L; Hafke A; Brandhorst G; Braulke F; Haase D; Armbrust T; Cameron S; Ramadori G; Oellerich M; Walson P
    Ther Drug Monit; 2011 Oct; 33(5):632-43. PubMed ID: 21912334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies.
    Xu Y; Fang W; Zeng W; Leijen S; Woolf EJ
    Anal Bioanal Chem; 2012 Dec; 404(10):3037-48. PubMed ID: 23099526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia.
    Lee J; Jung SY; Choi MY; Park JS; Park SK; Lim SA; Cho KH; Oh SY; Ha J; Kim DW; Lee J
    J Clin Pharm Ther; 2020 Oct; 45(5):1006-1013. PubMed ID: 32022312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass Spectrometry.
    Verweij-van Wissen CP; de Graaff-Teulen MJ; de Kanter CT; Aarnoutse RE; Burger DM
    Ther Drug Monit; 2015 Oct; 37(5):626-33. PubMed ID: 25627404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
    Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry.
    Ansari M; Uppugunduri CR; Déglon J; Théorêt Y; Versace F; Gumy-Pause F; Ozsahin H; Dayer P; Desmules J; Daali Y
    Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1437-46. PubMed ID: 22592987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: From method development to clinical application.
    da Silva LC; Grando AP; de Baco LS; Hahn RZ; Ferreira Filho AF; Brucker N; Linden R; Antunes MV
    J Pharm Biomed Anal; 2023 Oct; 235():115539. PubMed ID: 37517245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS.
    Linder C; Andersson M; Wide K; Beck O; Pohanka A
    Bioanalysis; 2015; 7(16):2031-9. PubMed ID: 26327183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DBS-LC-MS/MS assay for caffeine: validation and neonatal application.
    Bruschettini M; Barco S; Romantsik O; Risso F; Gennai I; Chinea B; Ramenghi LA; Tripodi G; Cangemi G
    Bioanalysis; 2016 Sep; 8(18):1893-902. PubMed ID: 27532249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting.
    Knapen LM; Beer Y; Brüggemann RJM; Stolk LM; Vries F; Tjan-Heijnen VCG; Erp NPV; Croes S
    J Pharm Biomed Anal; 2018 Feb; 149():106-113. PubMed ID: 29112898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients.
    Iacuzzi V; Posocco B; Zanchetta M; Montico M; Marangon E; Poetto AS; Buzzo M; Gagno S; Buonadonna A; Guardascione M; Casetta B; Toffoli G
    PLoS One; 2019; 14(11):e0225225. PubMed ID: 31743371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Center punch" and "whole spot" bioanalysis of apixaban in human dried blood spot samples by UHPLC-MS/MS.
    Zheng N; Yuan L; Ji QC; Mangus H; Song Y; Frost C; Zeng J; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():66-74. PubMed ID: 25746754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS.
    Berm EJ; Brummel-Mulder E; Paardekooper J; Hak E; Wilffert B; Maring JG
    Anal Bioanal Chem; 2014 Apr; 406(9-10):2349-53. PubMed ID: 24493333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites.
    Peeters LEJ; Feyz L; Hameli E; Zwart T; Bahmany S; Daemen J; van Gelder T; Versmissen J; Koch BCP
    Ther Drug Monit; 2020 Jun; 42(3):460-467. PubMed ID: 31593031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.
    Knippenberg B; Page-Sharp M; Salman S; Clark B; Dyer J; Batty KT; Davis TM; Manning L
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4940-55. PubMed ID: 27270283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of imatinib targeted delivery in human leukocytes.
    Kralj E; Žakelj S; Trontelj J; Pajič T; Preložnik Zupan I; Černelč P; Ostanek B; Marc J; Kristl A
    Eur J Pharm Sci; 2013 Sep; 50(1):123-9. PubMed ID: 23643738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men.
    Belsey SL; Ireland R; Lang K; Kizilors A; Ho A; Mufti GJ; Bisquera A; De Lavallade H; Flanagan RJ
    Ther Drug Monit; 2017 Oct; 39(5):499-504. PubMed ID: 28767619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.